PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 08: Articles 3501-4000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Making "responsible" men: planning the family in Egypt.
  2. Male contraception: views to the 21st century, Bethesda, MD, USA, 9-10 September 1999.
  3. Male contraceptive pill would be acceptable to men and women.
  4. Male contraceptive shows promise.
  5. Male fertility as affected by hydroxyurea: clinical application / contraceptive potential.
  6. Male hormonal contraception: a safe, acceptable and reversible choice [editorial]
  7. Mali: contraceptive logistics system. Review of accomplishments and lessons learned (1988-1998) [Mali : Système de logistique contraceptive. Bilan des accomplissements et des enseignements tirés (1988-1998)]
  8. Margaret Sanger, birth control pioneer.
  9. Mass media, ideation, and behavior: a longitudinal analysis of contraceptive change in the Philippines.
  10. Maverick reproductive scientists and the production of contraceptives, 1915-2000+.
  11. Meclizine for prevention of nausea associated with use of emergency contraceptive pills : a randomized trial. [La méclizine pour la prévention de la nausée associée à la prise de pilules contraceptives : une étude aléatoire.]
  12. Medico-legal problems of contraceptive practice. [Problemas medico-legales de la consulta de contracepcion.]
  13. A medicolegal evaluation of reversible contraceptives.
  14. The men's role in family planning of Soc Son district.
  15. Menstrual cycle symptom variation in a community sample of women using and not using oral contraceptives.
  16. Mexico: contraceptive logistics system. Review of accomplishments and lessons learned -- nongovernmental organizations (1992-1999) [México: sistema logístico de anticoncepción. Reseña de los logros y las lecciones aprendidas - organizaciones no gubernamentales (1992-1999)]
  17. Mifepristone as contraception and emergency contraception.
  18. Mifepristone: emergency contraception and other uses.
  19. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
  20. Monitoring quality of care in family planning by the quick investigation of quality (QIQ): country reports. [Supervisión de la calidad de la atención en la planificación familiar mediante la investigación rápida de calidad (QIQ, quick investigation of quality): informes nacionales.]
  21. Monthly combined injectable becomes first new method of U.S. contraceptive since '93. FDA approves Lunelle from Pharmacia Corp. News alert.
  22. Multidisciplinary learning in family planning clinics.
  23. National module of continuing education for logistics management of contraceptive products: participants' version. [Module national de formation continue pour la gestion logistique des produits contraceptifs : version participant.]
  24. National reproductive health guidelines. Vol. 1: Family planning. [Guias nacionales de salud reproductiva. Tomo I: Planificacion familiar.]
  25. National reproductive health guides. Volume I: Family planning. [Guias nacionales de salud reproductiva. Tomo I. Planificación familiar.]
  26. The need for family planning. Remaining challenges.
  27. The need for systematic reviews in family planning.
  28. New "mini-cap" barrier contraceptive.
  29. New days, new ways?: modernization, sexual attitudes and contraceptive knowledge among adolescent women in a traditional state in Mexico. [Tiempos nuevos, ¿formas nuevas?: modernización, actitudes sexuales y conocimiento anticonceptivo entre las adolescentes en un estado tradicional de México.]
  30. New methods of family planning: implications for intimate behavior.
  31. New rules on family planning : a good compromise, or a dangerous precedent? [Nouvelles règles sur le planning familial : un bon compromis ou un dangereux précédent ?]
  32. New survey measures fertility and family planning trends in India.
  33. Newer agents for hormonal contraception in the male.
  34. NGO Networks for Health family planning / reproductive health strategy.
  35. Nigeria's population policy: family planning requirements (1990-2010)
  36. On the dynamics of contraceptive use in Pakistan.
  37. Operations research for family planning: a simplified guide.
  38. Opposing views on contraceptives presented.
  39. Oral contraception update.
  40. Oral contraceptive failures among women terminating their pregnancy.
  41. Oral contraceptive pills: the best bet for contraception?
  42. Oral contraceptive use by teenage women does not affect peak bone mass: a longitudinal study.
  43. Oral contraceptives and breast cancer: a note of caution for high-risk women [editorial]
  44. Oral contraceptives and cardiovascular disease -- an end to the debate? Discussion.
  45. Oral contraceptives and cardiovascular risk -- an end to the debate?
  46. Oral contraceptives and fatal pulmonary embolism.
  47. Oral contraceptives for adolescents: benefits and safety. ACOG educational bulletin number 256, December 1999.
  48. An overview of family planning methods and practices.
  49. Parenting the pill: early testing of the contraceptive pill.
  50. Patterns of contraceptive use in Indonesia.
  51. Pharmacodynamics of oral contraceptives (OC) and combined oral contraceptives.
  52. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring.
  53. The pill and men's involvement in contraception.
  54. Plan B (levonorgestrel). The next generation of emergency contraception.
  55. Plant products for contraception: how to make it a reality?
  56. A pocket guide to managing contraception, 2000-2001 edition.
  57. Pocket guide to managing contraceptive supplies. Revised.
  58. Population and family planning projections, 1989 to 2020. Kenya.
  59. Post-abortion contraceptive acceptability in Blantyre, Malawi.
  60. Postpartum contraceptive use among adolescent mothers.
  61. Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function.
  62. Predictions : the future of family planning. [Prédictions : avenir du planning familial.]
  63. President puts renewed emphases on family planning.
  64. The pros and cons of the oral contraceptive pill.
  65. Protection of RU-486 as contraception, emergency contraception and as an abortifacient under the law of contraception.
  66. Provider knowledge about emergency contraception in Ghana. [Connaissances des prestataires en matière de contraception au Ghana.]
  67. Ready accessibility to contraceptives in Nepal.
  68. Recent advances in natural family planning.
  69. Religious differentials in desire for additional children and contraceptive use in Kerala.
  70. Reproduction, compositional demography, and economic growth: family planning in England long before the fertility decline.
  71. Reproductive health approach to family planning: implications for evaluating its impact.
  72. The right to a free choice. Family planning in the context of reproductive health. [El derecho a la libre decision. La planificacion familiar en el contexto de la salud reproductiva.]
  73. The right to family planning in 10 world religions.
  74. Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen / progestogen contraceptives. [Risque de cancer du sein en rapport avec l'usage de contraceptifs injectables au progestogène et à la combinaison estrogène/progestogène.]
  75. Risk of cardiovascular disease in relation to oral contraceptive use with and without blood-pressure screening.
  76. Risk of fatal pulmonary embolism with oral contraceptives.
  77. Role of education in the use of contraception.
  78. The role of Family Planning Australia in the South Pacific countries.
  79. Saving Women's Lives, Protecting Women's Health: White House World Health Day ceremony on family planning.
  80. Saving women's lives, protecting women's health. U.S. global leadership in family planning.
  81. Sayings and facts: family formation and contraception in poor women in metropolitan Buenos Aires. [Los dichos y los hechos: formacion de la familia y anticoncepcion en mujeres pobres del conurbano de Buenos Aires.]
  82. School-based health centers and the birth control debate.
  83. School-based health centers and the birth control debate.
  84. The science, medicine, and future of contraception.
  85. Selective home visits for motivation: evidence from an urban intervention on non-users of family planning.
  86. Sexual health knowledge, determinants of sexual behaviour and use of contraceptives among female secondary school students in Ibadan, Nigeria.
  87. Shifting away from doorstep distribution of contraceptives in urban Bangladesh: effects on discontinuation and acceptance of family planning.
  88. Should profitability determine the availability of effective contraception [letter]
  89. Should we still advise infertile couples to use (barrier) contraception before IVF down-regulation?
  90. Simple methods of natural family planning.
  91. Smoking, oral contraceptives, and cardiovascular reactivity to stress. [Tabagisme, contraceptifs oraux, et réactivité cardiovasculaire au stress.]
  92. Snapshot: family planning maintains salary, staff levels.
  93. The social and economic consequences of family planning use: the case of southern Philippines.
  94. Social networks, ideation, and contraceptive behavior in Bangladesh: a longitudinal analysis.
  95. Socio-economic status, fertility preferences and contraceptive change in sub-Saharan Africa.
  96. Sociocultural determinants of contraceptive method choice in Goa and Kerala, India.
  97. Statement on emergency contraception.
  98. Status of fertility, contraceptive use and prevalence of reproductive tract infections (RTIs) among slum dwellers in Delhi.
  99. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population.
  100. The strategic approach to the introduction of DMPA as an opportunity to improve quality of care for all contraceptive methods in Viet Nam.
  101. Studies on the effects of steroid hormone contraceptives on lipid, lipoprotein and apolipoprotein metabolism in Chinese women.
  102. Subdermal contraceptive implants. A CPD self-assessment test. Review.
  103. A survey of GP views on intra-uterine contraception.
  104. Survey on social marketing contraceptive availability in urban Zambia 1999.
  105. Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives.
  106. Tanzania. Integration of contraceptive products into the Medical Stores Department's distribution system, June 1997 - July 2000.
  107. Target free approach in family planning -- a critique.
  108. Teens' contraceptive use marked by inconsistency.
  109. Training reinforcement improves family planning counseling and may be cost-effective.
  110. Translocation of a Copper 7 intra-uterine contraceptive device with subsequent penetration of the caecum: case report and review.
  111. Trends in sexual activity and contraceptive use among teens.
  112. Trends in the use of modern contraception in Africa: 1986-1998.
  113. U.S. trials on contraceptive gel begin via the Internet.
  114. Uganda Quality of Care Survey of Family Planning and Antenatal Care Services.
  115. Uncertain aims and tacit negotiation: birth control practices in Britain, 1925-50.
  116. An unfulfilled human right: family planning in Guatemala. [Un derecho fundamental que no se cumple: planificación familiar en Guatemala.]
  117. Unmet need for family planning -- analysis of NFHS data for selected states in India.
  118. The unmet need for family planning.
  119. USAID support for family planning and reproductive health programs in Brazil.
  120. The use of oral contraceptive pharmaceutical sample packs by adolescent health care providers.
  121. Vaginal bleeding patterns in Nigerian users of nomegestrol acetate subdermal contraceptive implant.
  122. The voiceless and the new population policy. Misguided family planning priorities.
  123. What Kenyan men think about family planning.
  124. Who has told you to do this thing? Toward a feminist interpretation of contraceptive diffusion in Rhodesia, 1970-1980.
  125. Why aren't U.S. women using long-acting contraception?
  126. Will women accept randomization in a clinical trial of hormonal contraceptives?
  127. Women can continue hormonal contraceptives and hormonal replacement therapy before surgery.
  128. Women's lives: a study of life histories and family planning. Abridged version.
  129. Women, men, and contraceptive sterilization.
  130. Young people's sex advice services; delays, triggers and contraceptive use.
  131. Zambia: implications of health sector reform for contraceptive logistics.
  132. Zambian women applaud family planning policy.
  133. Zero growth: long-term effect of China's family planning program.
  134. Contraception and adolescents.
  135. American Academy of Pediatrics policy statement: Contraception and adolescents (RE9841)
  136. Antibodies to human ZP3 induce reversible contraception in transgenic mice with "humanized" zonae pellucidae.
  137. Assessing recall and understanding of informed consent in a contraceptive clinical trial.
  138. Barriers to uptake and use of modern methods of contraception in developing countries.
  139. Bone density in a population of long term oral contraceptive pill users does not differ from that in menstruating women.
  140. Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 micrograms ethinyl estradiol combined with 150 micrograms desogestrel or 75 micrograms gestodene.
  141. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
  142. Contraception in teenage Nigerian school girls.
  143. Contraceptive efficacy of daily administration of 0.5 mg mifepristone.
  144. Contraceptive knowledge, attitude and practices of men in rural Maharashtra.
  145. Contraceptive methods used and preferred by men and women.
  146. Contraceptive status and sexual behavior in women over 35 years of age in India.
  147. Contraceptive switching in Bangladesh.
  148. Correlates of visit regularity among family planning clients in urban Yemen.
  149. Correlation of endocrine profiles with bleeding patterns during use of Nestorone contraceptive implants.
  150. Determinants of contraceptive discontinuation in six developing countries.
  151. Do incentives matter? -- Evaluation of a family planning program in India.
  152. Do young women have specific problems in contraceptive use and counselling?
  153. Effect of low-dose oral contraceptives on androgenic markers and acne.
  154. Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations.
  155. Establishing an educational programme for nurses to supply emergency hormonal contraception (combined method) to protocol.
  156. Explanations of unmet need for contraception in Chitwan, Nepal.
  157. Factors affecting contraceptive use and behavior in Kocaeli, Turkey.
  158. Family planning program effects on contraceptive use in Morocco, 1992-1995.
  159. First time issue of oral hormonal contraception by nurses.
  160. A fixed formula to define the fertile window of the menstrual cycle as the basis of a simple method of natural family planning.
  161. Household organization, women's autonomy, and contraceptive behavior in southern Ethiopia.
  162. Initial UK experience of the levonorgestrel-releasing contraceptive intravaginal ring.
  163. The intrauterine contraceptive device: an often-forgotten and maligned method of contraception.
  164. Issue of emergency hormonal contraception through a casualty department in a community hospital.
  165. Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
  166. A multicentre efficacy and safety study of the single contraceptive implant Implanon.
  167. Oral contraception and other factors in relation to back disorders in women: findings in a large cohort study.
  168. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.
  169. A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol.
  170. Research and quality control in natural family planning with relational database systems.
  171. Serum leptin concentrations in women taking oral contraceptives.
  172. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study.

     

  173. The trimonthly combination oral contraceptive regimen: is it cost effective?
  174. Contraceptive procurement: a checklist of essential actions.
  175. Implementation challenges of reproductive health, including family planning and sexual health: issues concerning the integration of reproductive health components.
  176. Impact of contraceptive methods on women's lives: the case of tubal ligation. [Conseqüências do uso de métodos anticoncepcionais na vida das mulheres: o caso da laqueadura tubária.]
  177. Japan again refuses to approve birth control pill.
  178. Fertility preferences and contraceptive change in developing countries.
  179. Mexico: informing service providers and factory workers about emergency contraception. [México: información a prestadores de servicios y trabajadores industriales acerca de la anticoncepción de emergencia.]
  180. Comparing alternative products in the provision of emergency contraception.
  181. Testing strategies to improve access to emergency contraception pills: prescription vs. prophylactic distribution.
  182. Assessing the potential demand for and effectiveness of integrating STI / HIV management services with Zimbabwe National Family Planning Council's clinic-based family planning services.
  183. Family planning program effort in Egypt's governorates.
  184. Women's empowerment, family planning, and civil society: lessons learned from research with women's NGOs.
  185. Birth control distribution will be allowed in schools, board decides.
  186. Comprehensive reproductive health and family planning training curriculum. Module 4: Combined oral contraceptives and progestin-only pills.
  187. Comprehensive reproductive health and family planning training curriculum. Module 6: DMPA injectable contraceptive. Revised.
  188. A pocket guide to managing contraception. Millennium edition 1999-2000.
  189. Emergency contraception - an update.
  190. Role of religion in fertility and family planning among Muslims in India.
  191. The quality of family planning services in Uttar Pradesh from the perspective of service providers.
  192. BenCost. Version 4. A computer program for estimating the financial benefits and costs of family planning programs.
  193. Use of commercial and government sources of family planning and maternal and child health care.
  194. Charging fees for family planning services.
  195. Expanding commercial sector participation in family planning.
  196. Improving the quality of services and contraceptive acceptance in the postabortion period in three public-sector hospitals in Bolivia.
  197. Issues in the financing of family planning services in sub-Saharan Africa.
  198. The need for additional funds for family planning in sub-Saharan Africa.
  199. Health and family planning indicators: a tool for results frameworks. Volume I.
  200. Two sides of the same coin or a toss of the coin?: family planning services and family cap implementation.
  201. Capacity building approach in health and family planning in Bangladesh.
  202. Three new methods for male contraception.
  203. Family planning access increases contraceptive practice, even among women who do not intend to use a method.
  204. Putting unmet need to the test: community-based distribution of family planning in Pakistan.
  205. Men's knowledge of and attitudes toward birthspacing and contraceptive use in Jordan.
  206. Emergency contraception: knowledge, attitudes and practices among Brazilian obstetrician-gynecologists.
  207. Prevention first: a three-pronged strategy to integrate family planning program efforts against HIV and sexually transmitted infections.
  208. Education and nonuse of contraceptives among poor women in Chiapas, Mexico.
  209. Increasing efficiency to meet future demand: family planning services provided by the Mexican Ministry of Health.
  210. The relationship of social affiliation and interpersonal discussion to family planning knowledge, attitudes and practice.
  211. Fertility, contraceptive use and family planning program activity in the Islamic Republic of Iran.
  212. Family planning attitudes and use in Nigeria: a factor analysis.
  213. The impact of multimedia family planning promotion on the contraceptive behavior of women in Tanzania.
  214. Fertility and family planning trends in Karachi, Pakistan.
  215. Measuring family planning program effort at the provincial level: a Vietnam application.
  216. Pharmacists limit women's access to emergency contraception. ACOG news release.
  217. Contraceptive in a cuppa.
  218. Forgettable teen contraceptive sparks fury.
  219. Why family planning matters./Pourquoi la planification familiale est importante./Por que es importante la planificacion familiar.
  220. Commentary: Oral contraceptives and myocardial infarction: reassuring new findings.
  221. Emergency contraception: is it time to change method?
  222. Migraine and stroke in young women. Authors' results suggest that all types of migraine are contraindications to oral contraceptives [letter]
  223. Migraine and stroke in young women: case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
  224. Mortality associated with oral contraceptive use. Authors generalise their results to cohort that was never studied [letter]
  225. Mortality associated with oral contraceptive use. Confounding might have accounted for results [letter]
  226. Mortality associated with oral contraceptive use. Medical profession needs to examine facts [letter]
  227. Mortality associated with oral contraceptive use. Relative risk of liver cancer remains high [letter]
  228. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study.
  229. Oral contraception and health [editorial]
  230. Oral contraception and health [editorial]
  231. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
  232. Questionnaire study of use of emergency contraception among teenagers.
  233. The third generation oral contraceptive controversy.
  234. 1998 contraceptive social marketing statistics.
  235. 2000 CPT guidance. Contraceptive procurement tables.
  236. 22 countries: tax relief for vaccines, ORS, and contraceptives.
  237. A 40-year-old woman considering contraception, 1 year later.
  238. Abdominal wall pain caused by cutaneous nerve entrapment in an adolescent girl taking oral contraceptive pills.
  239. Abnormal Papanicolaou smears, genital tract infections, and contraception.
  240. Abortion as a method of birth control: a case study of hazards of abortion in Macedonia.
  241. Abortion in Ljubljana, Slovenia: a method of contraception or an emergency procedure?
  242. Abstinence promotion and the provision of information about contraception in public school district sexuality education policies.
  243. Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion.
  244. Access to "Jiggasha program: a family planning communication approach" and its exposure to the selected background characteristics.
  245. Acquired APC resistance and oral contraceptives: differences between two functional tests.
  246. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
  247. Advance elder care decision making: a model of family planning.
  248. Advertising and marketing; contraceptives get good reception on prime time.
  249. Age at first contraceptive information and risk taking among college women.
  250. Ambivalent feelings about parenthood may lead to inconsistent contraceptive use -- and pregnancy.
  251. Analyzing contraceptive failure [letter]
  252. Analyzing contraceptive failure [letter]
  253. Analyzing contraceptive failure. Drs. Hilgers and Stanford reply: [letter]
  254. Are all contraceptive failures unintended pregnancies? Evidence from the 1995 National Survey of Family Growth.
  255. Are husbands a barrier to women's family planning use? The case of Morocco.
  256. Area variations in use of modern contraception in rural Bangladesh: a multilevel analysis.
  257. Asia's population and family planning programmes: leaders in strategic communication.
  258. Assessment of oral contraceptive pill continuation in young women.
  259. Attitude of rural women towards contraceptive and its use.
  260. Attitudes toward family planning in Russia: research results from Moscow and Ivanovo.
  261. Attitudes towards family planning: inter-provincial comparisons of Lusaka and Copperbelt, Zambia.
  262. Avoiding unwanted pregnancy -- the role of communication, information and knowledge in the use of contraception among young Norwegian women.
  263. Balancing effectiveness, side-effects and work: women's perceptions and experiences with modern contraceptive technology in Cambodia.
  264. Barriers to the use of IUDs as emergency contraception.
  265. Benefits and risks of oral contraceptives.
  266. The "best contraceptive" and other approaches.
  267. Beyond family planning. A case study of National Population Policy of Nigeria.
  268. Big Macs, Marlboros and color-coded contraceptives.
  269. Biological coagulation findings in third-generation oral contraceptives.
  270. Birth control or controlling birth? A critical interrogation of two new contraceptive technologies using popular education practices and principles [abstract]
  271. Bone mineral density in women using depot medroxyprogesterone acetate for contraception.
  272. Breast cancer and oral contraceptive use in Asian-American women.
  273. Breastfeeding and contraception. [Stillen und Verhuten.]
  274. Bundling a pregnancy test with the Yuzpe regimen of emergency contraception.
  275. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers.
  276. Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks.
  277. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke.
  278. Causes and consequences of oral contraceptive noncompliance.
  279. Causes for discontinuation of injectable contraception at the Sale prefecture level. [Les causes d'abandon de la contraception injectable au niveau de la prefecture de Sale.]
  280. Challenges to the development of new contraceptive technology in the 21st century.
  281. Change amidst continuity: the Family Planning Movement of Indonesia.
  282. Checklist for ruling out pregnancy among family-planning clients in primary care.
  283. Choice and changes of contraceptive methods after primiparous delivery in Shanghai.
  284. Chronic diseases and contraceptive use.
  285. Client participation and provider communication in family planning counseling: transcript analysis in Kenya.
  286. Client-provider interaction: family planning counseling. [Slide presentation]
  287. Clinical audit of the process of referral to genitourinary medicine of patients found to be chlamydia positive in a family planning service.
  288. Clinical contraceptives: situation in rural Bangladesh.
  289. Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception.
  290. Clinician / patient interaction: communicating the benefits and risks of oral contraceptives.
  291. A clinician's response to the oral contraceptive thrombosis controversy.
  292. A cohort study of oral contraceptive use and risk of benign breast disease.
  293. Coitus-dependent family planning methods: observations from Bangladesh.
  294. A collaborative approach to management of chlamydial infection among teenagers seeking contraceptive care in a community setting.
  295. The combined oral contraceptive pill -- Are poor communication systems responsible for loss of confidence in this contraceptive method?
  296. Combining GUM and contraceptive services for young people: profile of an innovative clinic.
  297. Combining qualitative with quantitative approaches to study contraceptive pill use.
  298. Community resources, family processes and adolescents' attitudes, aspirations, and sexual and contraceptive behavior [abstract]
  299. Companies commit to emergency contraception -- have you?
  300. Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone / ethinyl estradiol triphasic)
  301. A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm.
  302. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
  303. Comparing contraceptive use surveys of young people in the United Kingdom.
  304. Comparison of continuation rates for hormonal contraception among adolescents.
  305. Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome.
  306. Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high-density lipoprotein particles.
  307. Comparison of three single doses of mifepristone as emergency contraception: a randomised trial.
  308. Composite indicators for contraceptive logistics management.
  309. A comprehensive assessment of the quality of services provided by family planning field workers in one major area of Dhaka city, Bangladesh.
  310. Conclusions: the relative safety of modern oral contraceptives.
  311. Concordant and discordant effects on cardiovascular risks exerted by oestrogen and progestogen in women using oral contraception and hormone replacement therapy.
  312. Condom practices of urban teens using Norplant contraceptive implants, oral contraceptives, and condoms for contraception.
  313. Condom use and contraception non-use amongst 16-19 year olds: a within subjects comparison.
  314. Consanguineous marriage and differentials in age at marriage, contraceptive use and fertility in Pakistan.
  315. Consensus conference on combination oral contraceptives and cardiovascular disease.
  316. Contraception and abortions. [Prevensjon og aborter.]
  317. Contraception and cardiovascular disorders.
  318. Contraception and young people: the condom club.
  319. Contraception by subcutaneous implants of levonorgestrel (Norplant). Burkina Faso experience. [La contraception par les implants sous-cutanes de levonorgestrel (Norplant). Experience africaine du Burkina Faso.]
  320. Contraception counts: state-by-state information.
  321. Contraception during first sexual intercourse: a survey of 467 13-21 year old young women living in Nantes. [La contraception au cours du premier rapport sexuel: enquete realisee aupres de 467 jeunes filles de 13 a 21 ans dans l'agglomeration nantaise.]
  322. Contraception during menopause. [Verhutung in den Wechseljahren.]
  323. Contraception in East and West Germany before and after the revolution of 1989. [Verhutung in Ost und West vor und nach der Wende.]
  324. Contraception in France: an assessment after 30 years of liberalization.
  325. Contraception in the prepill era.
  326. Contraception-21.
  327. Contraception: gypsy versus non-gypsy women. [Anticoncepcion: gitanas frente a payas.]
  328. Contraceptive characteristics: the perceptions and priorities of men and women.
  329. Contraceptive choices for women with disabilities.
  330. Contraceptive coverage laws proliferate in 1999.
  331. Contraceptive coverage, abortion dominate 1999 state, court activity.
  332. Contraceptive decision-making: the Wachagga of Kilimanjaro, Tanzania.
  333. Contraceptive discontinuation and the client's experience of method use and services. [Interruption de la contraception et expérience par le client de l'utilisation et des services d'une méthode.]
  334. Contraceptive effectiveness of two spermicides: a randomized trial.
  335. Contraceptive effectiveness. What should the counseling message be?
  336. Contraceptive efficacy of the personal hormone monitoring system Persona.
  337. Contraceptive equity bills gain momentum in state legislatures.
  338. Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth.
  339. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth.
  340. Contraceptive introduction reconsidered: a new methodology for policy and program development.
  341. Contraceptive logistics guidelines for refugee settings. Draft.
  342. Contraceptive methods: knowledge sources rated by women and men.
  343. Contraceptive options for perimenopausal women.
  344. Contraceptive patch tested.
  345. Contraceptive pill has no long-term ill effects -- British study.
  346. Contraceptive pill in Japan.
  347. Contraceptive potential of peptide antibiotics [letter]
  348. The contraceptive practice rate would go up to more than 60 percent.
  349. Contraceptive sponge returns.
  350. Contraceptive status and sexual function of climacteric Chinese women.
  351. Contraceptive technologies and consumer choices.
  352. Contraceptive use and pregnancy decision making among women with HIV.
  353. Contraceptive use during lactation in Nigeria.
  354. Contraceptive use dynamics of Asian women in Britain.
  355. Contraceptive use for birth spacing in sub-Saharan Africa [abstract]
  356. Contraceptive use in Australia: evidence from the 1995 National Health Survey.
  357. A correlative study of factors associated with contraceptive prevalence differentials in rural Uttar Pradesh.
  358. Cost-effectiveness of family planning and maternal health service delivery strategies in rural Bangladesh.
  359. Counseling and service-based family planning: Luwan, Shanghai.
  360. Counseling of birth control patients [letter]
  361. Counseling of birth control patients. Response [letter]
  362. Covert method use among urban Zambian women is tied to poor spousal communication on contraception.
  363. Creating linkages between incomplete abortion treatment and family planning services in Kenya.
  364. A critical analysis of family planning programme in Bangladesh.
  365. A critical assessment of family planning programme in Madhya Pradesh, India.
  366. Cultural and psychosocial factors affecting contraceptive use and abortion in two provinces of Turkey.
  367. Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. A multicenter, randomized comparison of levonorgestrel / ethinyl estradiol (100 micrograms / 20 micrograms) and norethindrone / ethinyl estradiol (1000 micrograms / 20 micrograms)
  368. Cycle control with oral contraceptives: a review of the literature.
  369. CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences.
  370. Data collection of population and family planning, [Indonesia] [Kumpulan data: kependudukan dan keluarga berencana Indonesia.]
  371. Dating couples and their relationships: intimacy and contraceptive use.
  372. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
  373. Depo-Provera: an ideal contraceptive for adolescents?
  374. Depo-Provera: costs eat up clinic contraceptive budgets.
  375. Detectable errors in NSFG 1995 contraceptive and sexual nonintercourse calendars.
  376. Detection of the human 70-kD and 60-kD heat shock proteins in the vagina: relation to microbial flora, vaginal pH, and method of contraception.
  377. The determinants of contraceptive discontinuation in northern India: a multilevel analysis of calendar data.
  378. Developing a national family planning / reproductive health clinical training system in Kenya.
  379. Developing strategies for improving the quality and performance of clinical contraceptive services: a review.
  380. Diabetic women need effective contraception.
  381. The differential risk of oral contraceptives: the impact of full exposure history.
  382. Diffusion of contraceptives among Hispanic female adolescents [abstract]
  383. Disabled have many needs for contraception.
  384. DISH intensifies family planning and HIV testing.
  385. DISH Project. Information, education and communication phase III, March 1999 - August 1999. Evaluation plan for family planning campaign, HIV counseling and testing campaign.
  386. Distance learning. Retraining module in reproductive health / family planning and management. Guide for trainers / facilitators. [Apprentissage a distance. Module de recyclage en sante de la reproduction / planification familiale et gestion. Guide des encadreurs / facilitateurs.]
  387. Distance learning. Retraining module in reproductive health / family planning and management. Student guide. [Apprentissage a distance. Module de recyclage en sante de la reproduction / planification familiale et gestion. Guide des apprenantes.]
  388. Distance learning. Retraining module in reproductive health / family planning and management. Volume I: Family planning. [Apprentissage a distance. Module de recyclage en sante de la reproduction / planification familiale et gestion. Volume I: Planification familiale.]
  389. Distance learning. Retraining module in reproductive health / family planning and management. Volume II: Management. [Apprentissage a distance. Module de recyclage en sante de la reproduction / planification familiale et gestion. Volume II: Gestion.]
  390. Distribution along a stages-of-behavorial-change continuum for condom and contraceptive use among women accessed in different settings.
  391. Does contraceptive discontinuation matter?: quality of care and fertility consequences.
  392. Does religion matter in contraceptive use among Ghanaian women?
  393. Donor support for contraceptive commodities -- 1997.
  394. Dual provision or duplication? A survey of family planning provision.
  395. Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives.
  396. Dynamics of contraceptive use in a rural community of Haryana.
  397. The effect of 1-year use of the CuT 380A and oral contraceptive pills on hemoglobin and ferritin levels.
  398. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 micrograms) and ethinyl estradiol (15 micrograms) on ovarian activity.
  399. Effect of age on the response of the hypothalamo-pituitary-ovarian axis to a combined oral contraceptive.
  400. Effect of family planning on women's lives in China.
  401. Effect of oral contraceptives containing 20 and 35 micrograms ethinly estradiol on urinary prostacyclin and thromboxane metabolite levels in smokers and nonsmokers.

     

  402. Effect of price and access on contraceptive use.
  403. Effect of troglitazone on the pharmacokinetics of an oral contraceptive agent.
  404. Effect on stroke of different progestagens in low oestrogen dose oral contraceptives [letter]
  405. Effectiveness of contraceptive technology update training: improved family planning / reproductive health knowledge and stated practices of service providers in Moldova.
  406. Effects of an entertainment-education radio soap opera on family planning behavior in Tanzania.
  407. The effects of family planning workers' contact on fertility preferences: evidence from Bangladesh.
  408. Effects of hormonal contraceptives on bone mineral density.
  409. Effects of husband involvement on postabortion patients' recovery and use of contraception in Egypt.
  410. Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.
  411. The effects of maternal-child health service utilization on subsequent contraceptive use in Morocco.
  412. The effects of oral contraceptive use on iron and copper concentrations in breast milk.
  413. Effects of oral contraceptives on hemostasis and thrombosis.
  414. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
  415. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives.
  416. Effects of three types of long-acting contraceptive implants on menstrual blood loss in 89 women.
  417. The effects on ovarian activity of a monophasic oral contraceptive with 100 micrograms levonorgestrel and 20 micrograms ethinyl estradiol.
  418. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 micrograms levonorgestrel and 20 micrograms ethinyl estradiol (Alesse)
  419. Efficacy of methods for determining ovulation in a natural family planning program.
  420. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
  421. Egypt Indepth Study on the Reasons for Nonuse of Family Planning. Results of a panel survey in Upper Egypt.
  422. Emergency contraception [letter]
  423. Emergency contraception -- the sooner the better. [Nodprevensjon -- jo for, jo bedre.]
  424. Emergency contraception advances women's rights.
  425. Emergency contraception and Catholic hospitals.
  426. Emergency contraception in a travel context [editorial]
  427. Emergency contraception in a travel context.
  428. Emergency contraception in Mexico City: what do health care providers and potential users know and think about it?
  429. Emergency contraception in Nairobi, Kenya: knowledge, attitudes and practices among policymakers, family planning providers and clients, and university students.
  430. Emergency contraception update.
  431. Emergency contraception use up -- new ECP arrives.
  432. Emergency contraception.
  433. Emergency contraception. [Anticoncepcion de emergencia.]
  434. Emergency contraception. Author's reply [letter]
  435. Emergency contraception. Contraception, not abortion: an analysis of laws and policy around the world.
  436. Emergency contraception: an anomalous position in the family planning repertoire?
  437. Emergency contraception: change in knowledge of women attending for termination of pregnancy from 1984 to 1996.
  438. Emergency contraception: how effective is it?
  439. Emergency contraception: it can change our world. An interview with James Trussell.
  440. Emergency contraception: lack of awareness among patients presenting for pregnancy termination.
  441. Emergency contraceptive pills: common legal questions about prescribing, dispensing, repackaging, and advertising.
  442. Emergency contraceptives bring a little peace of mind.
  443. Emergency contraceptives now more high-profile.
  444. Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free interval.
  445. Endometrial histology in long-term users of the once-a-month injectable contraceptive Cyclofem.
  446. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
  447. Estrophasic dosing: a new concept in oral contraceptive therapy.
  448. Ethical foundations of client-centered care in family planning.
  449. Ethnicity and contraceptive use in sub-Saharan Africa: the case of Ghana.
  450. European multicenter study of natural family planning (1989-1995): efficacy and drop-out.
  451. Evaluation of a computerized contraceptive decision aid for adolescent patients.
  452. An evaluation of family planning programme in Uttar Pradesh, India.
  453. Expanding contraceptive choice: findings from Brazil.
  454. Experimental study on the effect of quality improvement strategies on family planning services continuation rates in Senegal. [Etude experimentale sur l'effet des strategies d'amelioration de la qualite sur le taux de continuite des services de planification familiale au Senegal.]
  455. Exploring young people's difficulties in talking about contraception: how can we encourage more discussion between partners?
  456. Facets of family planning in Africa and Asia: a note.
  457. Factor V Leiden and venous thromboembolism in a woman taking second generation oral contraceptives: a case report. [Czynnik V Leiden i zylna choroba zakrzepowo-zatorowa u kobiety stosujacej doustny srodek antykoncepcyjny II generacji: opis przypadku.]
  458. Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?
  459. Factors affecting source of family planning services in India.
  460. Factors affecting the contraceptive choice in a developing country.
  461. Factors affecting the performance of family planning workers: importance of geographical information systems in empirical analysis.
  462. Factors contributing to choice of family planning methods: a comparative study of Orissa and Punjab.
  463. Factors influencing family planning method choice in west Bengal and Assam.
  464. Factors responsible for family planning acceptance with single child: findings from a study in Karnataka.
  465. The facts. Contraceptive coverage in the Federal Employees Health Benefits Program.
  466. The facts. Emergency contraception: an important component of women's rights.
  467. The facts. The Equity in Prescription Insurance and Contraceptive Coverage Act (EPICC)
  468. Families accept Vietnam's need for contraception. Condom promotion leads to shortages.
  469. Family planning and adoption promotion: new proposals, long-standing issues.
  470. Family planning and child protection [editorial]
  471. Family Planning and Demographic Yearbook 1998.
  472. Family planning and family decision making in Nusa Tenggara Timur.
  473. Family planning and family doctors in Estonia [letter]
  474. Family Planning and Maternal and Child Health Project in Morocco. Phase V. Consultation report, October 3-16, 1999. Documentation of the safe motherhood pilot project. [Projet de Planification Familiale et Sante Maternelle et Infantile. Phase V. Rapport de consultation du 3 au 16 octobre 1999. Documentation du projet pilote maternite sans risque.]
  475. Family Planning and Maternal and Child Health Project in Morocco. Phase V. Consultation report. Childhood illness in Morocco: practical representations and therapy. [Projet de Planification Familiale et Sante Maternelle et Infantile au Maroc. Phase V. Rapport de consultation. Les maladies de l'enfant au Maroc: representations pratiques et recours therapeutiques.]
  476. Family Planning and Maternal and Child Health Project in Morocco. Phase V. Consultation report. Report for supervision of trainers and workshop for gynecologists. [Projet de Planification Familiale et Sante Maternelle et Infantile au Maroc. Phase V. Rapport de consultation. Compte rendu pour la supervision des formatrices et l'atelier a l'intention des medecins gynecologues.]
  477. Family Planning and Maternal and Child Health Project in Morocco. Phase V. Consultation report. Support to the training workshop on standards development and quality monitoring, October 20 to November 5, 1999. [Projet de Planification Familiale et Sante Maternelle et Infantile. Phase V. Rapport de consultation. Appui a l'Atelier de Formation sur l'Elaboration des Standards et le Suivi de la Qualite, 20 octobre au 5 novembre, 1999.]
  478. Family Planning and Maternal and Child Health Project in Morocco. Phase V. Consultation report. Training in counseling and communication skills for midwifery personnel. [Projet de Planification Familiale et Sante Maternelle et Infantile au Maroc. Phase V. Rapport de consultation. Formation aux habiletes d'aide et de communication du personnel accoucheur.]
  479. Family Planning and Maternal and Child Health project in Morocco. Phase V. Revised 1998-99 plan of action. Activity programming 1999. [Projet de Planification Familiale et Sante Maternelle et Infantile au Maroc. Phase V. Revision du Plan d'Action 1998-99. Programmation des Activites 1999.]
  480. Family planning and parenthood needs of women with severe mental illness: clinicians' perspective.
  481. Family planning and sexual behaviour in the era of STDs and HIV / AIDS: a case of Nakuru district, Kenya.
  482. Family planning and the politics of population in Tanzania: international to local discourse.
  483. Family planning and the Roman Catholic Church: an empirical analysis of the Philippine experience in the light of the encyclical Humanae Vitae, 1970-1990.
  484. Family planning clinic characteristics and their influence on contraceptive behavior and pregnancy rates in Alabama, 1994-1996 [abstract]
  485. Family planning funding through four federal-state programs, FY 1997.
  486. Family planning in Indonesia during an economic crisis.
  487. Family planning in the context of sexual and reproductive health and rights. [Familienplanung im Kontext sexueller und reproduktiver Gesundheit und Rechte.]
  488. Family planning method standards in Morocco. [Les standards des methodes de planification familiale au Maroc.]
  489. Family planning methods and practice: Africa. 2nd ed.
  490. Family planning of minority groups: Asian women and seasonal workers [abstract]
  491. Family planning old-age insurance: a means of helping ageing farmers in China.
  492. Family planning prevents abortions.
  493. Family planning program effects on method awareness, contraceptive use, and fertility: revisiting evidence from the 1980s [abstract]
  494. Family planning program in Guangxi.
  495. Family planning program structure and performance in West Africa.
  496. Family planning programme in Indonesia: the case of IUD users.
  497. Family planning programme in Vietnam. An evaluation.
  498. Family planning promotion in Cameroon: content analysis of messages and impact of an audiovisual communication campaign. [La promotion de la planification familiale au Cameroun: analyse de contenu des messages et impact d'une campagne de communication audiovisuelle.]
  499. Family Planning Quality Survey, Istanbul 1998 report.
  500. Family planning saves lives.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.